Prestige Wealth Management Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.9K Hold
46
﹤0.01% 511
2026
Q1
$4.25K Hold
46
﹤0.01% 594
2025
Q4
$4.7K Buy
+46
New +$4.12K ﹤0.01% 590
2022
Q2
Sell
-24
Closed -$2K 1006
2022
Q1
$2K Hold
24
﹤0.01% 767
2021
Q4
$2K Hold
24
﹤0.01% 793
2021
Q3
$3K Hold
24
﹤0.01% 728
2021
Q2
$3K Sell
24
-8
-25% -$1.08K ﹤0.01% 727
2021
Q1
$5K Hold
32
﹤0.01% 613
2020
Q4
$4K Buy
32
+5
+19% +$575 ﹤0.01% 622
2020
Q3
$3K Buy
27
+14
+108% +$1.28K ﹤0.01% 619
2020
Q2
$1K Hold
13
﹤0.01% 768
2020
Q1
$1K Buy
+13
New +$998 ﹤0.01% 748

Other funds holding GH

Prestige Wealth Management Group's GH Position: Q2 2026 in Review

Prestige Wealth Management Group held its Guardant Health (GH) position steady in Q2 2026 at 46 shares worth $6.9K. The position accounts for ﹤0.01% of the portfolio, ranked #511.

Prestige Wealth Management Group first reported a position in GH in Q1 2020 and has held it in 12 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Prestige Wealth Management Group held 46 shares of Guardant Health worth $6.9K as of Q2 2026.
  • Prestige Wealth Management Group left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #511 holding.
  • Prestige Wealth Management Group first reported a position in Guardant Health in Q1 2020 and has held it in 12 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.